EANS-DD: Marinomed Biotech AG
Notification concerning transactions by persons
performing managerial responsibilities pursuant to article 19 Market Abuse
Regulation (MAR)
--------------------------------------------------------------------------------
Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by
euro adhoc with the aim of a Europe-wide distribution. The issuer is
responsible for the content of this announcement.
--------------------------------------------------------------------------------
personal data:
responsible party:
name: aws Mittelstandsfonds Beteiligungs GmbH & Co KG (legal person)
--------------------------------------------------------------------------------
reason:
reason: responsible party is a legal person associate to a person with
managerial responsibilities
name and surname: Mag.(FH) Karl Lankmayr
function: Member of an administrative or supervisory board
--------------------------------------------------------------------------------
issuer information:
name: Marinomed Biotech AG
Legal Entity Identifier (LEI): 529900GN3B1EN80XF405
--------------------------------------------------------------------------------
information about deal:
ISIN: ATMARINOMED6
description of the financial instrument: Stock
type: acquisition
date: 01.02.2019; UTC+01:00
market: WIENER BOERSE AG, XWBO
currency: Euro
price volume
75 6666
total volume: 6666
total price: 499950
average price: 75
--------------------------------------------------------------------------------
end of announcement euro adhoc
--------------------------------------------------------------------------------
issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English
Original content of: Marinomed Biotech AG, transmitted by news aktuell